334 related articles for article (PubMed ID: 16607671)
1. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases.
Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M
Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671
[TBL] [Abstract][Full Text] [Related]
2. Specificity of aza-peptide electrophile activity-based probes of caspases.
Sexton KB; Kato D; Berger AB; Fonovic M; Verhelst SH; Bogyo M
Cell Death Differ; 2007 Apr; 14(4):727-32. PubMed ID: 17170749
[TBL] [Abstract][Full Text] [Related]
3. A general solid phase method for the preparation of diverse azapeptide probes directed against cysteine proteases.
Kato D; Verhelst SH; Sexton KB; Bogyo M
Org Lett; 2005 Dec; 7(25):5649-52. PubMed ID: 16321013
[TBL] [Abstract][Full Text] [Related]
4. Activity-based probes that target diverse cysteine protease families.
Kato D; Boatright KM; Berger AB; Nazif T; Blum G; Ryan C; Chehade KA; Salvesen GS; Bogyo M
Nat Chem Biol; 2005 Jun; 1(1):33-8. PubMed ID: 16407991
[TBL] [Abstract][Full Text] [Related]
5. Novel azapeptide inhibitors of hepatitis C virus serine protease.
Bailey MD; Halmos T; Goudreau N; Lescop E; Llinàs-Brunet M
J Med Chem; 2004 Jul; 47(15):3788-99. PubMed ID: 15239657
[TBL] [Abstract][Full Text] [Related]
6. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
7. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
[TBL] [Abstract][Full Text] [Related]
8. Cysteine proteases of malaria parasites.
Rosenthal PJ
Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
[TBL] [Abstract][Full Text] [Related]
9. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.
Ekici OD; Götz MG; James KE; Li ZZ; Rukamp BJ; Asgian JL; Caffrey CR; Hansell E; Dvorák J; McKerrow JH; Potempa J; Travis J; Mikolajczyk J; Salvesen GS; Powers JC
J Med Chem; 2004 Apr; 47(8):1889-92. PubMed ID: 15055989
[TBL] [Abstract][Full Text] [Related]
10. Cysteine protease inhibition by azapeptide esters.
Magrath J; Abeles RH
J Med Chem; 1992 Nov; 35(23):4279-83. PubMed ID: 1447732
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase synthesis of double-headed epoxysuccinyl activity-based probes for selective targeting of papain family cysteine proteases.
Verhelst SH; Bogyo M
Chembiochem; 2005 May; 6(5):824-7. PubMed ID: 15776409
[No Abstract] [Full Text] [Related]
12. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
13. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
[TBL] [Abstract][Full Text] [Related]
14. Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases.
Löser R; Frizler M; Schilling K; Gütschow M
Angew Chem Int Ed Engl; 2008; 47(23):4331-4. PubMed ID: 18404765
[No Abstract] [Full Text] [Related]
15. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J
Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M
J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575
[TBL] [Abstract][Full Text] [Related]
17. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.
Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM
J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases.
Sadaghiani AM; Verhelst SH; Gocheva V; Hill K; Majerova E; Stinson S; Joyce JA; Bogyo M
Chem Biol; 2007 May; 14(5):499-511. PubMed ID: 17524981
[TBL] [Abstract][Full Text] [Related]
19. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
Xing R; Hanzlik RP
J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
[TBL] [Abstract][Full Text] [Related]
20. Activity-based fingerprinting and inhibitor discovery of cysteine proteases in a microarray.
Uttamchandani M; Liu K; Panicker RC; Yao SQ
Chem Commun (Camb); 2007 Apr; (15):1518-20. PubMed ID: 17406693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
